Drug Eluting Stents Market Analysis & Trends - Product and Drugs Used - Forecast to 2025

  • ID: 3951911
  • Report
  • 160 pages
  • Accuray Research LLP
1 of 4

FEATURED COMPANIES

  • Abbott Vascular Inc
  • Arterius Ltd
  • Biotronik SE & Co. KG
  • Cordis Corporation
  • Johnson & Johnson
  • Meril Life Sciences
  • MORE
"Drug Eluting Stents Market Analysis & Trends - Product (Polymer-based Coatings, Non biodegradable Polymers, Nanoporous Surface and Polymer free Coatings)and Drugs Used (Anti-neoplastics, Immunosupressives and Enhanced Healing Factors) - Forecast to 2025"

The Global Drug Eluting Stents Market is poised to grow at a CAGR of around 3.8% over the next decade to reach approximately $9.45 billion by 2025. Some of the prominent trends that the market is Recent advancement in new generation DES with more biocompatible durable polymers, Proliferation of Drug Eluting Stents for Malignant Airway Obstruction, DES with inorganic coatings or porous surfaces are likely to promote enhanced endothelialisation and Growth Opportunities/Investment Opportunities.

Based on Product the market is categorized into Polymer-based Coatings and Polymer free Coatings. The Polymer-based Coatings segment is further divided as Biodegradable Polymers and Non biodegradable Polymers. Polymer free Coatings segment is further represented as Micro structured Surface, Micro porous Surface, Nanoporous Surface and Slotted Tubular Surface.

Based on Application the market is categorized into Coronary Artery Disease and Peripheral Artery Disease.

The Drugs Used segment market is classified as Anti-neoplastics, Immunosupressives, Migration Inhibitors and Enhanced Healing Factors.

This industry report analyzes the global markets for Drug Eluting Stents across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025.

The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

The Drug Eluting Stents Market report provides data tables, includes charts and graphs for visual analysis.

Regional Analysis:

North America
- US
- Canada
- Mexico

Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe

Asia Pacific
- China
- Japan
- India
- Australia
- New Zealand
- Rest of Asia

Middle East
- Saudi Arabia
- UAE
- Rest of Middle East

Latin America
- Argentina
- Brazil
- Rest of Latin America

Rest of the World
- Africa
- Caribbean

Report Highlights:

- The report provides a detailed analysis on current and future market trends to identify the investment opportunities
- Market forecasts till 2025, using estimated market values as the base numbers
- Key market trends across the business segments, Regions and Countries
- Key developments and strategies observed in the market
- Market Dynamics such as Drivers, Restraints, Opportunities and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2025
- Market opportunities and recommendations for new investments
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Vascular Inc
  • Arterius Ltd
  • Biotronik SE & Co. KG
  • Cordis Corporation
  • Johnson & Johnson
  • Meril Life Sciences
  • MORE
1 Market Outline
1.1 Research Methodology
1.1.1 Research Approach & Sources
1.2 Market Trends
1.3 Regulatory Factors
1.4 Product Analysis
1.5 Application Analysis
1.6 Strategic Benchmarking
1.7 Opportunity Analysis

2 Executive Summary

3 Market Overview
3.1 Current Trends
3.1.1 Recent advancement in new generation DES with more biocompatible durable polymers
3.1.2 Proliferation of Drug Eluting Stents for Malignant Airway Obstruction
3.1.3 DES with inorganic coatings or porous surfaces are likely to promote enhanced endothelialisation
3.1.4 Growth Opportunities/Investment Opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness
3.4.1 Bargaining power of suppliers
3.4.2 Bargaining power of buyers
3.4.3 Threat of substitutes
3.4.4 Threat of new entrants
3.4.5 Competitive rivalry

4 Drug Eluting Stents Market, By Product
4.1 Polymer-based Coatings
4.1.1 Polymer-based Coatings Market Forecast to 2025 (US$ MN)
4.1.1.1 Biodegradable Polymers
4.1.1.1.1 Biodegradable Polymers Market Forecast to 2025 (US$ MN)
4.1.1.2 Non biodegradable Polymers
4.1.1.2.1 Non biodegradable Polymers Market Forecast to 2025 (US$ MN)
4.2 Polymer free Coatings
4.2.1 Polymer free Coatings Market Forecast to 2025 (US$ MN)
4.2.1.1 Micro structured Surface
4.2.1.1.1 Micro structured Surface Market Forecast to 2025 (US$ MN)
4.2.1.2 Micro porous Surface
4.2.1.2.1 Micro porous Surface Market Forecast to 2025 (US$ MN)
4.2.1.3 Nanoporous Surface
4.2.1.3.1 Nanoporous Surface Market Forecast to 2025 (US$ MN)
4.2.1.4 Slotted Tubular Surface
4.2.1.4.1 Slotted Tubular Surface Market Forecast to 2025 (US$ MN)

5 Drug Eluting Stents Market, By Application
5.1 Coronary Artery Disease
5.1.1 Coronary Artery Disease Market Forecast to 2025 (US$ MN)
5.2 Peripheral Artery Disease
5.2.1 Peripheral Artery Disease Market Forecast to 2025 (US$ MN)

6 Drug Eluting Stents Market, By Drugs Used
6.1 Anti-neoplastics
6.1.1 Anti-neoplastics Market Forecast to 2025 (US$ MN)
6.2 Immunosupressives
6.2.1 Immunosupressives Market Forecast to 2025 (US$ MN)
6.3 Migration Inhibitors
6.3.1 Migration Inhibitors Market Forecast to 2025 (US$ MN)
6.4 Enhanced Healing Factors
6.4.1 Enhanced Healing Factors Market Forecast to 2025 (US$ MN)

7 Drug Eluting Stents Market, By Geography
7.1 North America
7.1.1 North America Market Forecast by Countries to 2025 (US$ MN)
7.1.1.1 US
7.1.1.2 Canada
7.1.1.3 Mexico
7.2 Europe
7.2.1 Europe Market Forecast by Countries to 2025 (US$ MN)
7.2.1.1 France
7.2.1.2 Germany
7.2.1.3 Italy
7.2.1.4 Spain
7.2.1.5 UK
7.2.1.6 Rest of Europe
7.3 Asia Pacific
7.3.1 Asia Pacific Market Forecast by Countries to 2025 (US$ MN)
7.3.1.1 China
7.3.1.2 Japan
7.3.1.3 India
7.3.1.4 Australia
7.3.1.5 New Zealand
7.3.1.6 Rest of Asia Pacific
7.4 Middle East
7.4.1 Middle East Market Forecast by Countries to 2025 (US$ MN)
7.4.1.1 Saudi Arabia
7.4.1.2 UAE
7.4.1.3 Rest of Middle East
7.5 Latin America
7.7.1 Latin America Market Forecast by Countries to 2025 (US$ MN)
7.7.1.1 Argentina
7.7.1.2 Brazil
7.7.1.3 Rest of Latin America
7.6 Rest of the World (RoW)
7.6.1 RoW Market Forecast by Countries to 2025 (US$ MN)
7.6.1.1 Africa
7.6.1.2 Caribbean

8 Key Player Activities
8.1 Acquisitions & Mergers
8.2 Agreements, Partnerships, Collaborations and Joint Ventures
8.3 Product Launch & Expansions
8.4 Other Activities

9 Leading Companies
9.1 Abbott Vascular Inc
9.2 Boston Scientific Corporation
9.3 AlviMedica Medical Technologies Inc
9.4 Amaranth Medical, Inc.
9.5 Bioabsorbable Therapeutics, Inc.
9.6 Biosensors International Group, Ltd
9.7 Genesis Technologies, LLC
9.8 Cordis Corporation
9.9 Medtronic Inc
9.10 Johnson & Johnson
9.11 Kyoto Medical Planning Co., Ltd.
9.12 BioSurfaces, Inc
9.13 Arterius Ltd
9.14 Meril Life Sciences
9.15 Relisys Medical Devices Limited
9.16 Biotronik SE & Co. KG
9.17 CARDIONOVUM GmbH
9.18 Elixir Medical Corporation
9.19 Stentys, SA
9.20 Envision Scientific Pvt. Ltd
9.21 HangZhou HuaAn Biotechnology Co.,Ltd
9.22 Sino Medical-Device Technology Co., Ltd
9.23 Terumo Corporation
9.24 XTENT, Inc.

List of Tables

Table 1 Global Drug Eluting Stents Market By Region, Market Forecast (2013-2025) (US $MN)
Table 2 Global Drug Eluting Stents Market By Product, Market Forecast (2013-2025) (US $MN)
Table 3 Global Drug Eluting Stents Market By Polymer-based Coatings, Market Forecast (2013-2025) (US $MN)
Table 4 Global Drug Eluting Stents Market By Biodegradable Polymers, Market Forecast (2013-2025) (US $MN)
Table 5 Global Drug Eluting Stents Market By Non biodegradable Polymers, Market Forecast (2013-2025) (US $MN)
Table 6 Global Drug Eluting Stents Market By Polymer free Coatings, Market Forecast (2013-2025) (US $MN)
Table 7 Global Drug Eluting Stents Market By Micro structured Surface, Market Forecast (2013-2025) (US $MN)
Table 8 Global Drug Eluting Stents Market By Micro porous Surface, Market Forecast (2013-2025) (US $MN)
Table 9 Global Drug Eluting Stents Market By Nanoporous Surface, Market Forecast (2013-2025) (US $MN)
Table 10 Global Drug Eluting Stents Market By Slotted Tubular Surface, Market Forecast (2013-2025) (US $MN)
Table 11 Global Drug Eluting Stents Market By Application, Market Forecast (2013-2025) (US $MN)
Table 12 Global Drug Eluting Stents Market By Coronary Artery Disease, Market Forecast (2013-2025) (US $MN)
Table 13 Global Drug Eluting Stents Market By Peripheral Artery Disease, Market Forecast (2013-2025) (US $MN)
Table 14 Global Drug Eluting Stents Market By Drugs Used, Market Forecast (2013-2025) (US $MN)
Table 15 Global Drug Eluting Stents Market By Anti-neoplastics, Market Forecast (2013-2025) (US $MN)
Table 16 Global Drug Eluting Stents Market By Immunosupressives, Market Forecast (2013-2025) (US $MN)
Table 17 Global Drug Eluting Stents Market By Migration Inhibitors, Market Forecast (2013-2025) (US $MN)
Table 18 Global Drug Eluting Stents Market By Enhanced Healing Factors, Market Forecast (2013-2025) (US $MN)
Table 19 North America Drug Eluting Stents Market By Country, Market Forecast (2013-2025) (US $MN)
Table 20 North America Drug Eluting Stents Market By Product, Market Forecast (2013-2025) (US $MN)
Table 21 North America Drug Eluting Stents Market By Polymer-based Coatings, Market Forecast (2013-2025) (US $MN)
Table 22 North America Drug Eluting Stents Market By Biodegradable Polymers, Market Forecast (2013-2025) (US $MN)
Table 23 North America Drug Eluting Stents Market By Non biodegradable Polymers, Market Forecast (2013-2025) (US $MN)
Table 24 North America Drug Eluting Stents Market By Polymer free Coatings, Market Forecast (2013-2025) (US $MN)
Table 25 North America Drug Eluting Stents Market By Micro structured Surface, Market Forecast (2013-2025) (US $MN)
Table 26 North America Drug Eluting Stents Market By Micro porous Surface, Market Forecast (2013-2025) (US $MN)
Table 27 North America Drug Eluting Stents Market By Nanoporous Surface, Market Forecast (2013-2025) (US $MN)
Table 28 North America Drug Eluting Stents Market By Slotted Tubular Surface, Market Forecast (2013-2025) (US $MN)
Table 29 North America Drug Eluting Stents Market By Application, Market Forecast (2013-2025) (US $MN)
Table 30 North America Drug Eluting Stents Market By Coronary Artery Disease, Market Forecast (2013-2025) (US $MN)
Table 31 North America Drug Eluting Stents Market By Peripheral Artery Disease, Market Forecast (2013-2025) (US $MN)
Table 32 North America Drug Eluting Stents Market By Drugs Used, Market Forecast (2013-2025) (US $MN)
Table 33 North America Drug Eluting Stents Market By Anti-neoplastics, Market Forecast (2013-2025) (US $MN)
Table 34 North America Drug Eluting Stents Market By Immunosupressives, Market Forecast (2013-2025) (US $MN)
Table 35 North America Drug Eluting Stents Market By Migration Inhibitors, Market Forecast (2013-2025) (US $MN)
Table 36 North America Drug Eluting Stents Market By Enhanced Healing Factors, Market Forecast (2013-2025) (US $MN)
Table 37 Europe Drug Eluting Stents Market By Country, Market Forecast (2013-2025) (US $MN)
Table 38 Europe Drug Eluting Stents Market By Product, Market Forecast (2013-2025) (US $MN)
Table 39 Europe Drug Eluting Stents Market By Polymer-based Coatings, Market Forecast (2013-2025) (US $MN)
Table 40 Europe Drug Eluting Stents Market By Biodegradable Polymers, Market Forecast (2013-2025) (US $MN)
Table 41 Europe Drug Eluting Stents Market By Non biodegradable Polymers, Market Forecast (2013-2025) (US $MN)
Table 42 Europe Drug Eluting Stents Market By Polymer free Coatings, Market Forecast (2013-2025) (US $MN)
Table 43 Europe Drug Eluting Stents Market By Micro structured Surface, Market Forecast (2013-2025) (US $MN)
Table 44 Europe Drug Eluting Stents Market By Micro porous Surface, Market Forecast (2013-2025) (US $MN)
Table 45 Europe Drug Eluting Stents Market By Nanoporous Surface, Market Forecast (2013-2025) (US $MN)
Table 46 Europe Drug Eluting Stents Market By Slotted Tubular Surface, Market Forecast (2013-2025) (US $MN)
Table 47 Europe Drug Eluting Stents Market By Application, Market Forecast (2013-2025) (US $MN)
Table 48 Europe Drug Eluting Stents Market By Coronary Artery Disease, Market Forecast (2013-2025) (US $MN)
Table 49 Europe Drug Eluting Stents Market By Peripheral Artery Disease, Market Forecast (2013-2025) (US $MN)
Table 50 Europe Drug Eluting Stents Market By Drugs Used, Market Forecast (2013-2025) (US $MN)
Table 51 Europe Drug Eluting Stents Market By Anti-neoplastics, Market Forecast (2013-2025) (US $MN)
Table 52 Europe Drug Eluting Stents Market By Immunosupressives, Market Forecast (2013-2025) (US $MN)
Table 53 Europe Drug Eluting Stents Market By Migration Inhibitors, Market Forecast (2013-2025) (US $MN)
Table 54 Europe Drug Eluting Stents Market By Enhanced Healing Factors, Market Forecast (2013-2025) (US $MN)
Table 55 Asia Pacific Drug Eluting Stents Market By Country, Market Forecast (2013-2025) (US $MN)
Table 56 Asia Pacific Drug Eluting Stents Market By Product, Market Forecast (2013-2025) (US $MN)
Table 57 Asia Pacific Drug Eluting Stents Market By Polymer-based Coatings, Market Forecast (2013-2025) (US $MN)
Table 58 Asia Pacific Drug Eluting Stents Market By Biodegradable Polymers, Market Forecast (2013-2025) (US $MN)
Table 59 Asia Pacific Drug Eluting Stents Market By Non biodegradable Polymers, Market Forecast (2013-2025) (US $MN)
Table 60 Asia Pacific Drug Eluting Stents Market By Polymer free Coatings, Market Forecast (2013-2025) (US $MN)
Table 61 Asia Pacific Drug Eluting Stents Market By Micro structured Surface, Market Forecast (2013-2025) (US $MN)
Table 62 Asia Pacific Drug Eluting Stents Market By Micro porous Surface, Market Forecast (2013-2025) (US $MN)
Table 63 Asia Pacific Drug Eluting Stents Market By Nanoporous Surface, Market Forecast (2013-2025) (US $MN)
Table 64 Asia Pacific Drug Eluting Stents Market By Slotted Tubular Surface, Market Forecast (2013-2025) (US $MN)
Table 65 Asia Pacific Drug Eluting Stents Market By Application, Market Forecast (2013-2025) (US $MN)
Table 66 Asia Pacific Drug Eluting Stents Market By Coronary Artery Disease, Market Forecast (2013-2025) (US $MN)
Table 67 Asia Pacific Drug Eluting Stents Market By Peripheral Artery Disease, Market Forecast (2013-2025) (US $MN)
Table 68 Asia Pacific Drug Eluting Stents Market By Drugs Used, Market Forecast (2013-2025) (US $MN)
Table 69 Asia Pacific Drug Eluting Stents Market By Anti-neoplastics, Market Forecast (2013-2025) (US $MN)
Table 70 Asia Pacific Drug Eluting Stents Market By Immunosupressives, Market Forecast (2013-2025) (US $MN)
Table 71 Asia Pacific Drug Eluting Stents Market By Migration Inhibitors, Market Forecast (2013-2025) (US $MN)
Table 72 Asia Pacific Drug Eluting Stents Market By Enhanced Healing Factors, Market Forecast (2013-2025) (US $MN)
Table 73 Middle East Drug Eluting Stents Market By Country, Market Forecast (2013-2025) (US $MN)
Table 74 Middle East Drug Eluting Stents Market By Product, Market Forecast (2013-2025) (US $MN)
Table 75 Middle East Drug Eluting Stents Market By Polymer-based Coatings, Market Forecast (2013-2025) (US $MN)
Table 76 Middle East Drug Eluting Stents Market By Biodegradable Polymers, Market Forecast (2013-2025) (US $MN)
Table 77 Middle East Drug Eluting Stents Market By Non biodegradable Polymers, Market Forecast (2013-2025) (US $MN)
Table 78 Middle East Drug Eluting Stents Market By Polymer free Coatings, Market Forecast (2013-2025) (US $MN)
Table 79 Middle East Drug Eluting Stents Market By Micro structured Surface, Market Forecast (2013-2025) (US $MN)
Table 80 Middle East Drug Eluting Stents Market By Micro porous Surface, Market Forecast (2013-2025) (US $MN)
Table 81 Middle East Drug Eluting Stents Market By Nanoporous Surface, Market Forecast (2013-2025) (US $MN)
Table 82 Middle East Drug Eluting Stents Market By Slotted Tubular Surface, Market Forecast (2013-2025) (US $MN)
Table 83 Middle East Drug Eluting Stents Market By Application, Market Forecast (2013-2025) (US $MN)
Table 84 Middle East Drug Eluting Stents Market By Coronary Artery Disease, Market Forecast (2013-2025) (US $MN)
Table 85 Middle East Drug Eluting Stents Market By Peripheral Artery Disease, Market Forecast (2013-2025) (US $MN)
Table 86 Middle East Drug Eluting Stents Market By Drugs Used, Market Forecast (2013-2025) (US $MN)
Table 87 Middle East Drug Eluting Stents Market By Anti-neoplastics, Market Forecast (2013-2025) (US $MN)
Table 88 Middle East Drug Eluting Stents Market By Immunosupressives, Market Forecast (2013-2025) (US $MN)
Table 89 Middle East Drug Eluting Stents Market By Migration Inhibitors, Market Forecast (2013-2025) (US $MN)
Table 90 Middle East Drug Eluting Stents Market By Enhanced Healing Factors, Market Forecast (2013-2025) (US $MN)
Table 91 Latin America Drug Eluting Stents Market By Country, Market Forecast (2013-2025) (US $MN)
Table 92 Latin America Drug Eluting Stents Market By Product, Market Forecast (2013-2025) (US $MN)
Table 93 Latin America Drug Eluting Stents Market By Polymer-based Coatings, Market Forecast (2013-2025) (US $MN)
Table 94 Latin America Drug Eluting Stents Market By Biodegradable Polymers, Market Forecast (2013-2025) (US $MN)
Table 95 Latin America Drug Eluting Stents Market By Non biodegradable Polymers, Market Forecast (2013-2025) (US $MN)
Table 96 Latin America Drug Eluting Stents Market By Polymer free Coatings, Market Forecast (2013-2025) (US $MN)
Table 97 Latin America Drug Eluting Stents Market By Micro structured Surface, Market Forecast (2013-2025) (US $MN)
Table 98 Latin America Drug Eluting Stents Market By Micro porous Surface, Market Forecast (2013-2025) (US $MN)
Table 99 Latin America Drug Eluting Stents Market By Nanoporous Surface, Market Forecast (2013-2025) (US $MN)
Table 100 Latin America Drug Eluting Stents Market By Slotted Tubular Surface, Market Forecast (2013-2025) (US $MN)
Table 101 Latin America Drug Eluting Stents Market By Application, Market Forecast (2013-2025) (US $MN)
Table 102 Latin America Drug Eluting Stents Market By Coronary Artery Disease, Market Forecast (2013-2025) (US $MN)
Table 103 Latin America Drug Eluting Stents Market By Peripheral Artery Disease, Market Forecast (2013-2025) (US $MN)
Table 104 Latin America Drug Eluting Stents Market By Drugs Used, Market Forecast (2013-2025) (US $MN)
Table 105 Latin America Drug Eluting Stents Market By Anti-neoplastics, Market Forecast (2013-2025) (US $MN)
Table 106 Latin America Drug Eluting Stents Market By Immunosupressives, Market Forecast (2013-2025) (US $MN)
Table 107 Latin America Drug Eluting Stents Market By Migration Inhibitors, Market Forecast (2013-2025) (US $MN)
Table 108 Latin America Drug Eluting Stents Market By Enhanced Healing Factors, Market Forecast (2013-2025) (US $MN)
Table 109 RoW Drug Eluting Stents Market By Country, Market Forecast (2013-2025) (US $MN)
Table 110 RoW Drug Eluting Stents Market By Product, Market Forecast (2013-2025) (US $MN)
Table 111 RoW Drug Eluting Stents Market By Polymer-based Coatings, Market Forecast (2013-2025) (US $MN)
Table 112 RoW Drug Eluting Stents Market By Biodegradable Polymers, Market Forecast (2013-2025) (US $MN)
Table 113 RoW Drug Eluting Stents Market By Non biodegradable Polymers, Market Forecast (2013-2025) (US $MN)
Table 114 RoW Drug Eluting Stents Market By Polymer free Coatings, Market Forecast (2013-2025) (US $MN)
Table 115 RoW Drug Eluting Stents Market By Micro structured Surface, Market Forecast (2013-2025) (US $MN)
Table 116 RoW Drug Eluting Stents Market By Micro porous Surface, Market Forecast (2013-2025) (US $MN)
Table 117 RoW Drug Eluting Stents Market By Nanoporous Surface, Market Forecast (2013-2025) (US $MN)
Table 118 RoW Drug Eluting Stents Market By Slotted Tubular Surface, Market Forecast (2013-2025) (US $MN)
Table 119 RoW Drug Eluting Stents Market By Application, Market Forecast (2013-2025) (US $MN)
Table 120 RoW Drug Eluting Stents Market By Coronary Artery Disease, Market Forecast (2013-2025) (US $MN)
Table 121 RoW Drug Eluting Stents Market By Peripheral Artery Disease, Market Forecast (2013-2025) (US $MN)
Table 122 RoW Drug Eluting Stents Market By Drugs Used, Market Forecast (2013-2025) (US $MN)
Table 123 RoW Drug Eluting Stents Market By Anti-neoplastics, Market Forecast (2013-2025) (US $MN)
Table 124 RoW Drug Eluting Stents Market By Immunosupressives, Market Forecast (2013-2025) (US $MN)
Table 125 RoW Drug Eluting Stents Market By Migration Inhibitors, Market Forecast (2013-2025) (US $MN)
Table 126 RoW Drug Eluting Stents Market By Enhanced Healing Factors, Market Forecast (2013-2025) (US $MN)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
- Abbott Vascular Inc
- AlviMedica Medical Technologies Inc
- Amaranth Medical, Inc.
- Arterius Ltd
- BioSurfaces, Inc
- Bioabsorbable Therapeutics, Inc.
- Biosensors International Group, Ltd
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- CARDIONOVUM GmbH
- Cordis Corporation
- Elixir Medical Corporation
- Envision Scientific Pvt. Ltd
- Genesis Technologies, LLC
- HangZhou HuaAn Biotechnology Co.,Ltd
- Johnson & Johnson
- Kyoto Medical Planning Co., Ltd.
- Medtronic Inc
- Meril Life Sciences
- Relisys Medical Devices Limited
- Sino Medical-Device Technology Co., Ltd
- Stentys, SA
- Terumo Corporation
- XTENT, Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll